These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 16836501

  • 1. Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
    Levy JL, Pons F, Jouve E.
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):711-6. PubMed ID: 16836501
    [Abstract] [Full Text] [Related]

  • 2. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A, Carruthers J.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [Abstract] [Full Text] [Related]

  • 3. Long-term prospective follow-up of botulinum toxin treatment for facial rhytides.
    Bulstrode NW, Grobbelaar AO.
    Aesthetic Plast Surg; 2002 Jan; 26(5):356-9. PubMed ID: 12432474
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W.
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study.
    Levy JL, Servant JJ, Jouve E.
    J Cosmet Laser Ther; 2004 May; 6(1):16-20. PubMed ID: 15370408
    [Abstract] [Full Text] [Related]

  • 6. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
    Carruthers A, Bogle M, Carruthers JD, Dover JS, Arndt KA, Hsu TS, Poirier J.
    Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
    [Abstract] [Full Text] [Related]

  • 7. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A, Carruthers J, Cohen J.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [Abstract] [Full Text] [Related]

  • 8. Supraciliary wrinkles and botulinum toxin A.
    Ghalamkarpour F, Robati RM, Aryanejad F, Toossi P.
    Clin Exp Dermatol; 2010 Jun; 35(4):388-91. PubMed ID: 19874314
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
    Lowe NJ, Lask G, Yamauchi P, Moore D.
    J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366
    [Abstract] [Full Text] [Related]

  • 11. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.
    Cohen BL, Barboglio P, Rodriguez D, Gousse AE.
    Neurourol Urodyn; 2009 Dec; 28(3):205-8. PubMed ID: 19058190
    [Abstract] [Full Text] [Related]

  • 12. A new technique applying botulinum toxin in narrow and wide foreheads.
    Ozsoy Z, Genc B, Gözü A.
    Aesthetic Plast Surg; 2005 Dec; 29(5):368-72. PubMed ID: 16151661
    [Abstract] [Full Text] [Related]

  • 13. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.
    Ito H, Ito H, Nakano S, Kusaka H.
    Acta Neurol Scand; 2007 Apr; 115(4):271-4. PubMed ID: 17376126
    [Abstract] [Full Text] [Related]

  • 14. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C, Jankovic J, Duane D.
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [Abstract] [Full Text] [Related]

  • 15. [Botulinum toxin A in the treatment of wrinkles in the upper third of the face].
    Gassia V.
    Ann Dermatol Venereol; 2009 Oct; 136 Suppl 6():S299-305. PubMed ID: 19931689
    [Abstract] [Full Text] [Related]

  • 16. Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection.
    Hexsel D, Rutowitsch MS, de Castro LC, do Prado DZ, Lima MM.
    Dermatol Surg; 2009 Jun; 35(6):933-9; discussion 940. PubMed ID: 19397645
    [Abstract] [Full Text] [Related]

  • 17. Effect of volume and concentration on the diffusion of botulinum exotoxin A.
    Hsu TS, Dover JS, Arndt KA.
    Arch Dermatol; 2004 Nov; 140(11):1351-4. PubMed ID: 15545544
    [Abstract] [Full Text] [Related]

  • 18. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck.
    Spósito MM.
    Aesthetic Plast Surg; 2002 Nov; 26(2):89-98. PubMed ID: 12016492
    [Abstract] [Full Text] [Related]

  • 19. Alteration of Skin Mechanical Properties in Patients Undergoing Botulinum Toxin Type A Injections of Forehead Rhytides.
    Min P, Zhang Z, Grassetti L, Perdanasari AT, Torresetti M, Pu Z, Zhang Y, Han S, Marsili R, Zhang YX, di Benedetto G, Lazzeri D.
    Aesthetic Plast Surg; 2016 Jun; 40(3):410-20. PubMed ID: 26944891
    [Abstract] [Full Text] [Related]

  • 20. An objective assessment of botulinum toxin A effect on superficial skin texture.
    Dessy LA, Mazzocchi M, Rubino C, Mazzarello V, Spissu N, Scuderi N.
    Ann Plast Surg; 2007 May; 58(5):469-73. PubMed ID: 17452827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.